Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Prostate Cancer Prostatic Dis ; 14(1): 1-13, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20956994

RESUMO

Men with prostate cancer are reported as commonly using complementary and alternative medicine (CAM) but surveys have not recently been subjected to a rigorous systematic review incorporating quality assessment. Six electronic databases were searched using pre-defined terms. Detailed information was extracted systematically from each relevant article. Study reporting quality was assessed using a quality assessment tool, which demonstrated acceptable inter-rater reliability and produces a percentage score. In all, 42 studies are reviewed. All were published in English between 1999 and 2009; 60% were conducted in the United States. The reporting quality was mixed (median score = 66%, range 23-94%). Significant heterogeneity precluded formal meta-analysis. In all, 39 studies covering 11,736 men reported overall prevalence of CAM use; this ranged from 8 to 90% (median=30%). In all, 10 studies reported prevalence of CAM use specifically for cancer care; this ranged from 8 to 50% (median = 30%). Some evidence suggested CAM use is more common in men with higher education/incomes and more severe disease. The prevalence of CAM use among men with prostate cancer varies greatly across studies. Future studies should use standardised and validated data collection techniques to reduce bias and enhance comparability.


Assuntos
Terapias Complementares/estatística & dados numéricos , Pesquisas sobre Atenção à Saúde , Neoplasias da Próstata/terapia , Estudos Transversais , Humanos , Masculino , Reprodutibilidade dos Testes
2.
J Manipulative Physiol Ther ; 22(9): 622-7, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10626706

RESUMO

OBJECTIVE: This paper presents a management protocol for calcific tendinitis and describes its effective application in 2 cases of calcific tendinitis of the supraspinatus tendon in middle-aged women. CLINICAL FEATURES: Two patients presented to a chiropractic clinic with previously diagnosed calcific tendinitis of the supraspinatus tendon. Both patients complained of chronic pain and tenderness in the shoulder region and had a limited range of shoulder motion as a result of the pain. Radiographs demonstrated calcific deposits in the region of the supraspinatus tendon. INTERVENTION AND OUTCOMES: Both patients were admitted to a treatment protocol involving approximately 20 sessions of phonophoresis (driving of medication into tissue by ultrasound) with Movelat cream followed by cross-friction massage to the supraspinatus tendon and range of motion exercises. A second set of radiographs was requested. The calcific deposits, clearly seen on the previous radiographs, were no longer visible, and symptoms were resolved. At 4-month follow up, both patients continued to be symptom-free. CONCLUSION: The result of these studies indicates that the management of calcific tendinitis falls within the scope of chiropractic practice and supports the use of a trial period of conservative management in cases of calcific tendinitis before consideration of surgical treatment.


Assuntos
Ombro , Tendinopatia/terapia , Calcinose , Quiroprática/métodos , Doença Crônica , Protocolos Clínicos , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Dor/etiologia , Manejo da Dor , Radiografia , Ombro/diagnóstico por imagem , Tendinopatia/complicações , Tendinopatia/diagnóstico por imagem
3.
J Med Chem ; 26(10): 1353-60, 1983 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-6620297

RESUMO

The synthesis and antiinflammatory activity of a series of substituted (2-phenoxyphenyl)acetic acids are described. Initial screening in the adjuvant arthritis test showed that halogen substitution in the phenoxy ring enhanced activity considerably. Ulcerogenic potential, as measured by the minimum ulcerogenic dose (MUD), was low in almost all the acids tested. [2-(2,4-Dichlorophenoxy)phenyl]acetic acid possessed the most favorable combination of potency with low toxicity, including ulcerogenicity, and this compound is now in therapeutic use.


Assuntos
Anti-Inflamatórios/síntese química , Fenilacetatos/uso terapêutico , Animais , Anti-Inflamatórios/uso terapêutico , Artrite Experimental/tratamento farmacológico , Avaliação Pré-Clínica de Medicamentos , Indicadores e Reagentes , Ratos , Espectrofotometria Infravermelho , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA